{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:24:17Z","timestamp":1773091457575,"version":"3.50.1"},"reference-count":119,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1614,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1442-9071.2010.02435.x","type":"journal-article","created":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T15:31:45Z","timestamp":1288020705000},"page":"259-270","source":"Crossref","is-referenced-by-count":83,"title":["New therapeutic approaches in the treatment of diabetic keratopathy: a review"],"prefix":"10.1111","volume":"39","author":[{"given":"Hamdy","family":"Abdelkader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipika V","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles NJ","family":"McGhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raid G","family":"Alany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,4]]},"reference":[{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02169787","article-title":"Impairment of corneal epithelial barrier function in diabetics","volume":"227","author":"Gobbels","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00055735-199908000-00009","article-title":"Management of neurotrophic keratopathy","volume":"10","author":"Lambiase","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB3|cit3","first-page":"506","volume-title":"Current Ocular Therapy","author":"Mackie","year":"1995"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB4|cit4","first-page":"754","article-title":"The pathogenesis and treatment of persistent epithelial defects","volume":"81","author":"Cavanagh","year":"1976","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB5|cit5","first-page":"1339","volume-title":"Cornea: Fundamentals of Corneal and External Disease","author":"Groos","year":"1997"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB6|cit6","unstructured":"Wild S Roglic G Sicree R Green A King H Global burden of diabetes mellitus in 2000 http:\/\/www.who.int\/healthinfo\/statistics\/bod_diabetes.pdf"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJM199505043321807","article-title":"Prevention and treatment of the complications of diabetes mellitus","volume":"332","author":"Clark","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/diacare.21.1.143","article-title":"Diabetic retinopathy","volume":"21","author":"Aeillo","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00006324-198803000-00013","article-title":"A review of manifestations of diabetes mellitus in the anterior eye and cornea","volume":"65","author":"Herse","year":"1988","journal-title":"Am J Optom Physiol Opt"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB10|cit10","first-page":"1","volume-title":"Diabetes and the Eye","volume":"5","author":"Feman","year":"2000"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB11|cit11","first-page":"691","article-title":"Discoveries in research on diabetic keratopathy","volume":"72","author":"Cisarik-Fredenburg","year":"2001","journal-title":"Optometry"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/bjo.2004.055541","article-title":"Prevention of diabetic keratopathy","volume":"89","author":"Kaji","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB13|cit13","first-page":"180","article-title":"Diabetic keratopathy","volume":"79","author":"Schultz","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cytogfr.2004.09.003","article-title":"Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases","volume":"15","author":"Micera","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.exer.2004.11.013","article-title":"Nerve growth factor and corneal wound healing in dogs","volume":"80","author":"Woo","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/153537020222600711","article-title":"Corneal epithelial wound healing","volume":"226","author":"Lu","year":"2001","journal-title":"Exp Biol Med"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1350-9462(02)00042-3","article-title":"Cell-matrix and cell-cell interactions during corneal epithelial wound healing","volume":"22","author":"Suzuki","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1167\/iovs.07-1260","article-title":"Acute wound healing in the human central corneal epithelium appears to be independent of limbal stem cell influence","volume":"49","author":"Chang","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1167\/iovs.03-0189","article-title":"Effects of substance P and IGF-1 in cornea epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy","volume":"44","author":"Nagano","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB20|cit20","first-page":"2120","article-title":"Epidermal growth factor stimulates integrin mediated cell migration of cultured human corneal epithelial cells on fibronectin and arginine-glycine-aspartic acid peptide","volume":"36","author":"Maldonado","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.1041530102","article-title":"Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism","volume":"153","author":"Nishida","year":"1992","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00003226-199505000-00001","article-title":"Corneal woun healing modulation using basic fibroblast growth factor after excimer lasephotorefractive keratectomy","volume":"14","author":"David","year":"1995","journal-title":"Cornea"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1167\/iovs.03-0700","article-title":"Role of p38 MAP kinase in regulation of cell migration and proliferation in healing cornealepithelium","volume":"45","author":"Saika","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"21989","DOI":"10.1074\/jbc.M302650200","article-title":"p38 and ERK1\/2 coordinate cellular migration and proliferation in epithelial wound healing","volume":"278","author":"Sharma","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB25|cit25","first-page":"2544","article-title":"Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea","volume":"34","author":"Wilson","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB26|cit26","first-page":"2487","article-title":"Corneal epithelial cell attachment with endogenous laminin and fibronectin","volume":"34","author":"Ohji","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB27|cit27","first-page":"364","article-title":"Involvement of integrins with adhesion promoting, heparin-binding peptides of type IV collagen in cultured human corneal epithelial cells","volume":"36","author":"Maldonado","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB28|cit28","first-page":"1922","article-title":"Transforming growth factor-beta receptor expression in human cornea","volume":"38","author":"Joyce","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","article-title":"Topical treatment with nerve growth factor for corneal neurotrophic ulcers","volume":"338","author":"Lambiase","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-4835(92)90063-X","article-title":"Distribution of epidermal growth factor (EGF) receptors in rabbit corneal epithelial cells, keratocytes and endothelial cells, and the changes induced by transforming growth factor-beta 1","volume":"54","author":"Hongo","year":"1992","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB31|cit31","first-page":"3073","article-title":"Differentiation in cultured limbal epithelium as defined by keratin expression","volume":"32","author":"Kiritoshi","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB32|cit32","first-page":"2","article-title":"Growth factors and corneal epithelium","volume":"9","author":"Schultz","year":"1990","journal-title":"Cornea"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00003226-199001000-00002","article-title":"Corneal growth factors: a new generation of ophthalmic pharmaceuticals","volume":"9","author":"Tripathi","year":"1990","journal-title":"Cornea"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajo.2006.04.017","article-title":"Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy","volume":"142","author":"Schulze","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"41168","DOI":"10.1210\/en.136.10.4168","article-title":"Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-1 and IGF-II","volume":"136","author":"Gockerman","year":"1995","journal-title":"Endocrinology"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0955-2235(90)90008-8","article-title":"Growth factors in the eye","volume":"2","author":"McAvoy","year":"1990","journal-title":"Prog Growth Factor Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.0.CO;2-8","article-title":"Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea","volume":"169","author":"Nishida","year":"1996","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjp.0700923","article-title":"The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor- 1","volume":"120","author":"Nakamura","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1167\/iovs.05-0826","article-title":"Insulin-like growth factor-1 induces migration and expression of laminin-5 incultutured human corneal epithelial cells","volume":"47","author":"Lee","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/archopht.1997.01100160096021","article-title":"Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1","volume":"115","author":"Brown","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10384-009-0693-4","article-title":"Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients","volume":"53","author":"Chikamoto","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bjo.2007.130013","article-title":"Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy","volume":"92","author":"Yamada","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1242\/jcs.110.17.2089","article-title":"Insulin stimulates haptotactic migration of human epidermal keratinocytes through activation of NF-kappa B transcription factor","volume":"110","author":"Benoliel","year":"1987","journal-title":"J Cell Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archsurg.1968.01330190055012","article-title":"Acceleration of primary wound healing by insulin","volume":"96","author":"Rosenthal","year":"1968","journal-title":"Arch Surg"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB45|cit45","first-page":"9","article-title":"Topical application of insulin in the treatment of decubitus ulcers: a pilot study","volume":"25","author":"Van Ort","year":"1976","journal-title":"Nurs Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005373-199802000-00019","article-title":"Effects of insulin on wound healing","volume":"44","author":"Pierre","year":"1998","journal-title":"J Trauma"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/978-1-4615-0717-8_85","article-title":"Insulin, insulin receptor and insulin-like growth factor-I receptor on the human ocular surface","volume":"506","author":"Rocha","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/03009739709178930","article-title":"Insulin receptors in human ocular tissues. Immunohistochemical demonstration in normal and diabetic eyes","volume":"102","author":"Naeser","year":"1997","journal-title":"Ups J Med Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01221955","article-title":"Insulin receptors in cultured mouse retinal cells","volume":"16","author":"Thomopoulos","year":"1979","journal-title":"Diabetologia"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB50|cit50","first-page":"1681","article-title":"Comparison of insulin receptors from bovine retinal blood vessels and nonvascular retinal tissue","volume":"27","author":"Im","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2337\/diabetes.51.10.3055","article-title":"Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat","volume":"51","author":"Zagon","year":"2002","journal-title":"Diabetes"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB52|cit52","first-page":"2915","article-title":"Corneal structure and sensitivity in type 1 diabetes mellitus","volume":"41","author":"Rosenberg","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2337\/diabetes.55.04.06.db05-1581","article-title":"Insulin treatment ameliorate impaired corneal reepithelization in diabetic rats","volume":"55","author":"Zagon","year":"2006","journal-title":"Diabetes"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archopht.125.8.1082","article-title":"Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus","volume":"125","author":"Zagon","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00920-6","article-title":"Review on the systemic delivery of insulin via the ocular route","volume":"233","author":"Lee","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.pa.31.040191.002325","article-title":"Systemic delivery of polypeptide drugs through ocular route","volume":"31","author":"Chiou","year":"1991","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35\u2003years later","volume":"237","author":"Levi-Montalcini","year":"1987","journal-title":"Science"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB58|cit58","first-page":"1","article-title":"A role for nerve growth factor in nervous, endocrine and immune system","volume":"1","author":"Levi-Montalcini","year":"1990","journal-title":"Prog Neuroendocrinimuunol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB59|cit59","first-page":"1272","article-title":"Expression of nerve growth factors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases","volume":"39","author":"Lambiase","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB60|cit60","first-page":"692","article-title":"Neurotrophic factors in the human cornea","volume":"41","author":"You","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB61|cit61","first-page":"987","article-title":"The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture","volume":"43","author":"Touhami","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1167\/iovs.03-0037","article-title":"Presence and localization of neurotrophins and neurotrophin receptors in rat lacrimal gland","volume":"44","author":"Ghinelli","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1167\/iovs.06-1226","article-title":"Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation","volume":"48","author":"R\u00edos","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB64|cit64","first-page":"1963","article-title":"Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium","volume":"34","author":"Kruse","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB65|cit65","first-page":"2127","article-title":"Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells","volume":"36","author":"Lambiase","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","article-title":"Topical treatment with nerve growth factor for neurotrophic keratitis","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(00)00296-0","article-title":"Controlled release of nerve growth factor from a heparin-based cell ingrowth matrix","volume":"69","author":"Sakiyama-Elbert","year":"2000","journal-title":"J Control Release"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2005.03.005","article-title":"Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies","volume":"105","author":"Xie","year":"2005","journal-title":"J Control Release"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ejpb.2008.01.014","article-title":"Controlled nerve growth factor release from multi-plyalginate\/chitosan-based nerve conduits","volume":"69","author":"Pfister","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-1119(89)90404-6","article-title":"Synthesis and secretion of human growth factor by Saccharomyces cerevisiae","volume":"83","author":"Kanaya","year":"1989","journal-title":"Gene"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF00182801","article-title":"Biologically active humand and mouse nerve growth factors secreted by the yeast Saccharomyces cerevisiae","volume":"38","author":"Nishizawa","year":"1993","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-1119(92)90657-B","article-title":"Synthesis of the biologically active \u03b2-subunit of human nerve growth factor in Escherichia coli","volume":"110","author":"Negro","year":"1992","journal-title":"Gene"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1046\/j.1432-1327.2001.02232.x","article-title":"The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies","volume":"268","author":"Rattenholl","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1471-4159.1991.tb08256.x","article-title":"Physicochemical characterization of recombinant human nerve growth factor produced in insect cells with a baculovirus vector","volume":"57","author":"Barnett","year":"1991","journal-title":"J Neurochem"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-022X(01)00134-8","article-title":"Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps","volume":"47","author":"Allen","year":"2001","journal-title":"J Biochem Biophys Methods"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0006-291X(90)91364-X","article-title":"Production, purification and characterization of biologically active recombinant human nerve growth factor","volume":"171","author":"Iwane","year":"1990","journal-title":"Biochim Biophys Res Commun"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/303821a0","article-title":"Human beta-nerve growth factor gene sequence highly homologous to that of mouse","volume":"303","author":"Ullrich","year":"1983","journal-title":"Nature"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1016\/S0021-9258(18)68715-0","article-title":"Processing of the native growth factor precursor to form biologically active nerve growth factor","volume":"263","author":"Edwards","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.neuro.24.1.601","article-title":"Early days of the nerve growth factor proteins","volume":"24","author":"Shooter","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"18658","DOI":"10.1073\/pnas.0508734102","article-title":"Recombinant human nerve growth factor with a marked activity in vitro and in vivo","volume":"102","author":"Colangelo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB82|cit82","first-page":"2068","article-title":"Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet derived growth factor B, and interleukin-1 beta","volume":"37","author":"Li","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9394(14)71169-9","article-title":"Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112","volume":"119","author":"Hosotani","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00165937","article-title":"Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study","volume":"230","author":"Daniele","year":"1992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00003226-199703000-00010","article-title":"Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF-beta in the rabbit","volume":"16","author":"Jester","year":"1997","journal-title":"Cornea"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/1081-597X-19970701-11","article-title":"Effect of transforoming growth factor beta 1 on stromal haze following excimer laser photorefractive keratectomy in rabbits","volume":"13","author":"Mayers","year":"1997","journal-title":"J Refract Surg"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.ne.07.030184.001255","article-title":"Endogenous opioid: biology and function","volume":"7","author":"Akil","year":"1984","journal-title":"Ann Rev Neurosci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB88|cit88","first-page":"343","volume-title":"The Role of Endogenous Opioids and Opioid Receptors in Human and Animal Cancers","author":"Zagon","year":"1991"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-94-011-1540-7_3","volume-title":"Opioid Growth Factor Receptor in the Developing Nervous System","volume":"1","author":"Zagon","year":"1993"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0006-8993(91)91585-O","article-title":"Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system","volume":"542","author":"Zagon","year":"1991","journal-title":"Brain Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.11-12-03705.1991","article-title":"Endogenous opioids modulate neural survival in the developing avian ciliary ganglion","volume":"11","author":"Meriney","year":"1991","journal-title":"J Neurosci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0169-328X(94)90381-6","article-title":"Preproenkephalin mRNA expressionin the developing and adult rat brain","volume":"21","author":"Zagon","year":"1994","journal-title":"Mol Brain Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(93)90669-E","article-title":"Production and characterisation of polyclonal and monoclonal antibodies to the zeta (\u03b6) opioid receptor","volume":"630","author":"Zagon","year":"1993","journal-title":"Brain Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0024-3205(94)00597-4","article-title":"Opioid antagonist modulation of rat heart development","volume":"54","author":"McLaughlin","year":"1994","journal-title":"Life Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB95|cit95","first-page":"R645","article-title":"Opioid growth factor (OGF) inhibits DNA synthesis in mouse tongue epithelium in a circadian-dependent manner","volume":"267","author":"Zagon","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0014-4835(90)90051-U","article-title":"Identification of methionine enkephalin in the bovine by fast atom bombardment-mass spectrometry","volume":"51","author":"Tinsley","year":"1990","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/0196-9781(88)90205-7","article-title":"Purification, characterization, and localization of neuropeptides in the cornea","volume":"9","author":"Tinsley","year":"1989","journal-title":"Peptides"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB98|cit98","first-page":"R942","article-title":"Opioid growth factor modulates corneal epithelial outgrowth in tissue culture","volume":"268","author":"Zagon","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.brainresbull.2009.08.008","article-title":"Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review","volume":"81","author":"McLaughlin","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"R844","DOI":"10.1152\/ajpregu.00311.2009","article-title":"Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation","volume":"297","author":"Cheng","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB101|cit101","first-page":"73","article-title":"Reepithelialization of the human cornea is regulated by endogenous opioids","volume":"41","author":"Zagon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-8993(98)00427-2","article-title":"Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors","volume":"798","author":"Zagon","year":"1998","journal-title":"Brain Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-8993(98)00610-6","article-title":"Re-epithelialization of the rabbit cornea is regulated by opioid growth factor","volume":"803","author":"Zagon","year":"1998","journal-title":"Brain Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/jop.2006.0111","article-title":"Topically applied naltrexone restores corneal reepithelialization in diabetic rats","volume":"23","author":"Klocek","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.exer.2009.06.010","article-title":"Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats","volume":"89","author":"Klocek","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/archophthalmol.2009.270","article-title":"Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus","volume":"127","author":"Zagon","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jop.2006.22.377","article-title":"Corneal safety of topically applied naltrexone","volume":"22","author":"Zagon","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/archopht.124.11.1620","article-title":"Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA","volume":"124","author":"Zagon","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9394(00)00415-3","article-title":"Decreased substance P concentrations in tears from patients with corneal hypesthesia","volume":"129","author":"Yamada","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB110|cit110","first-page":"388","article-title":"Topical substance P and corneal epithelial wound closure in the rabbit","volume":"38","author":"Kingsley","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9394(88)90001-3","article-title":"Aldose reductase inhibitor(CT-112) eye drops for diabetic corneal epitheliopathy","volume":"105","author":"Ohashi","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1076\/ceyr.16.6.595.5076","article-title":"Effects of aldose reductase inhibitor, CT-112, on the corneal epithelial barrier of galactose-fed rats","volume":"16","author":"Yokoi","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1254\/jjp.76.321","article-title":"Repeated injections of nicergoline increase the nerve growth factor level in the aged rat brain","volume":"76","author":"Nishio","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0306-4522(01)00470-5","article-title":"Neuroprotection and aging of the cholinergic system: a role for the ergoline derivative nicergoline (Sermion)","volume":"109","author":"Giardino","year":"2002","journal-title":"Neuroscience"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1167\/iovs.08-2037","article-title":"Effects of nicergoline on corneal epithelial wound healing in rat eyes","volume":"50","author":"Kim","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/jop.1994.10.101","article-title":"Toxicity of insulin administered chronically to human eye in vivo","volume":"10","author":"Bartlett","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","article-title":"Nerve growth factor: from neurotrophin to neurokine","volume":"19","author":"Levi-Montalcini","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-510X(95)00007-O","article-title":"Update of the NGF saga","volume":"130","author":"Levi-Montalcini","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1442-9071.2010.02435.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10837450701481157","article-title":"Protein stability during freezing: separation of stresses and mechanisms of protein stabilization","volume":"12","author":"Bhatnagar","year":"2007","journal-title":"Pharm Dev Technol"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2010.02435.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1442-9071.2010.02435.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T16:32:39Z","timestamp":1636734759000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2010.02435.x"}},"subtitle":["Treatment of neurotrophic corneal ulcers"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02435.x","relation":{},"ISSN":["1442-6404"],"issn-type":[{"value":"1442-6404","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}